The ability of FGF21 to ameliorate signs of non-alcoholic fatty liver disease in mice depends on sex and diet
Consumption of high-calorie food leads to the development of obesity and non-alcoholic fatty liver disease (NAFLD). The pathogenesis of NAFLD depends on the composition of the diet. Administration of fibroblast growth factor 21 (FGF21) to obese mice improves metabolism and liver condition; however, the dependence of th...